A Featured Story on The MIT Technology Review, by Antonio Regalado (November 19, 2014) about how drug companies are using “giant database of human DNA information” for drug discovery.
Entitled The Search for Exceptional Genomes, this story provides an example of how Big Data can be used by drug manufacturers to explore new drugs.
…“This is going to be the major model of human disease research going forward,”
And then, this story also tells us about humans being a bit dysfunctional:
“…MacArthur’s analysis, completed in 2012, found that each of us has, on average, one entirely defective copy of about 80 genes, and another 20 genes for which neither copy works. In other words, everyone’s genome is a little dysfunctional…”